Emerging from the UK, retatrutide, a new molecule, is creating considerable interest within the medical community regarding its promise for weight management . This dual GIP and GLP-1 target agonist seems to provide a substantial benefit over existing therapies, showing encouraging results in preliminary clinical trials . Researchers think its dist